These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 17235298)

  • 21. pH-sensitive oncolytic adenovirus hybrid targeting acidic tumor microenvironment and angiogenesis.
    Choi JW; Jung SJ; Kasala D; Hwang JK; Hu J; Bae YH; Yun CO
    J Control Release; 2015 May; 205():134-43. PubMed ID: 25575865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oncolytic virotherapy for oral squamous cell carcinoma using replication-competent viruses.
    Saito K; Shirasawa H; Isegawa N; Shiiba M; Uzawa K; Tanzawa H
    Oral Oncol; 2009 Dec; 45(12):1021-7. PubMed ID: 19833547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antitumor Effects of Oncolytic Adenovirus-Carrying siRNA Targeting Potential Oncogene EphA3.
    Zhao Y; Li H; Wu R; Li S; Wang P; Wang H; Wang J; Zhou J
    PLoS One; 2015; 10(5):e0126726. PubMed ID: 25978371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combining oncolytic virotherapy and tumour vaccination.
    Bridle BW; Hanson S; Lichty BD
    Cytokine Growth Factor Rev; 2010; 21(2-3):143-8. PubMed ID: 20226716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oncolytic HSV as a vector in cancer immunotherapy.
    Li H; Zhang X
    Methods Mol Biol; 2010; 651():279-90. PubMed ID: 20686972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncolytic and immunologic cancer therapy with GM-CSF-armed vaccinia virus of Tian Tan strain Guang9.
    Deng L; Fan J; Guo M; Huang B
    Cancer Lett; 2016 Mar; 372(2):251-7. PubMed ID: 26803055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The utility of cells as vehicles for oncolytic virus therapies.
    Russell SJ; Peng KW
    Curr Opin Mol Ther; 2008 Aug; 10(4):380-6. PubMed ID: 18683103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antitumor activities of an oncolytic adenovirus equipped with a double siRNA targeting Ki67 and hTERT in renal cancer cells.
    Fang L; Cheng Q; Li W; Liu J; Li L; Xu K; Zheng J
    Virus Res; 2014 Mar; 181():61-71. PubMed ID: 24463503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Next-generation oncolytic vaccinia vectors.
    Thorne SH
    Methods Mol Biol; 2012; 797():205-15. PubMed ID: 21948478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Naturally oncolytic viruses.
    Roberts MS; Lorence RM; Groene WS; Bamat MK
    Curr Opin Mol Ther; 2006 Aug; 8(4):314-21. PubMed ID: 16955694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The fourth front against cancer. The first clinical trials to test engineered viruses that attack tumour cells have yielded promising results for future cancer therapies.
    Hunter P
    EMBO Rep; 2011 Jul; 12(8):769-71. PubMed ID: 21799527
    [No Abstract]   [Full Text] [Related]  

  • 32. Oncolytic HSV armed with platelet factor 4, an antiangiogenic agent, shows enhanced efficacy.
    Liu TC; Zhang T; Fukuhara H; Kuroda T; Todo T; Martuza RL; Rabkin SD; Kurtz A
    Mol Ther; 2006 Dec; 14(6):789-97. PubMed ID: 17045531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oncolytic viruses: extreme treatment for an extreme disease.
    Kaur B; Chiocca EA
    Future Microbiol; 2006 Dec; 1(4):351-3. PubMed ID: 17661625
    [No Abstract]   [Full Text] [Related]  

  • 34. Spotlight on… Gabriella Campadelli-Fiume.
    Campadelli-Fiume G
    FEMS Microbiol Lett; 2018 Jun; 365(11):. PubMed ID: 29873707
    [No Abstract]   [Full Text] [Related]  

  • 35. Newcastle disease virus as an oncolytic agent.
    Ravindra PV; Tiwari AK; Sharma B; Chauhan RS
    Indian J Med Res; 2009 Nov; 130(5):507-13. PubMed ID: 20090097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Panorama from the oncolytic virotherapy summit.
    Pol JG; Marguerie M; Arulanandam R; Bell JC; Lichty BD
    Mol Ther; 2013 Oct; 21(10):1814-8. PubMed ID: 24081122
    [No Abstract]   [Full Text] [Related]  

  • 37. Recent advances in the development of oncolytic viruses as cancer therapeutics. Foreword.
    Bell J; Kirn D
    Cytokine Growth Factor Rev; 2010; 21(2-3):83-4. PubMed ID: 20444639
    [No Abstract]   [Full Text] [Related]  

  • 38. Engineering Viruses to Fight Cancer.
    EBioMedicine; 2016 Jan; 3():1. PubMed ID: 26870830
    [No Abstract]   [Full Text] [Related]  

  • 39. United virus: the oncolytic tag-team against cancer!
    Le Boeuf F; Bell JC
    Cytokine Growth Factor Rev; 2010; 21(2-3):205-11. PubMed ID: 20227326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel oncolytic viruses: riding high on the next wave?
    Stanford MM; Bell JC; Vähä-Koskela MJ
    Cytokine Growth Factor Rev; 2010; 21(2-3):177-83. PubMed ID: 20219409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.